Biosimilars [Design Issues]

posted by drgunasakaran1  – 2012-02-06 14:57 (5241 d 20:11 ago) – Posting: # 8059
Views: 8,547

❝ […] kindly explain me can i enroll healthy subjects for biosimilars BA/BE study ?


Dear Mr.Vasu,

You can enroll healthy volunteers in the Pharmacokinetic studies required for Biosimilars like Interferon alpha See section 5 Clinical Studies (Page 5 of 7).

Efficacy and safety studies of Biosimilars will be done in patient population.

Kindly go through EMA's Product Specific Biosimilar Guidances.



Edit: Full quote removed. Please delete anything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Helmut]

Dr Gunasakaran Sambandan MD
Disclaimer: The replies/posts are my personal opinions, and they do not represent my company's views on the same. LinkedIn

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
138 visitors (0 registered, 138 guests [including 37 identified bots]).
Forum time: 12:08 CEST (Europe/Vienna)

I have never in my life learned anything
from any man who agreed with me.    Dudley Field Malone

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5